
Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
Objective: One of the goals of molecular diagnostics is integration into the clinical team to provide value added experience and personalized information ...
Typology: Summaries
1 / 1
This page cannot be seen from the preview
Don't miss anything!
Phan, R.T. Regional Molecular Pathology & Cytogenetics Laboratory The Permanente Medical Group, Kaiser Northern California Berkeley and San Jose, California
Objective: One of the goals of molecular diagnostics is integration into the clinical team to provide value added experience and personalized information for patient care. This presentation will highlight innovative ways to accomplish this goal in the filed of molecular pathology and cytogenetics.
Design:
Materials and Methods:
Results: This presentation will center on molecular pathology and cytogenetic testing utilization in clinical practice. Specifically, participants will come to understand the process of evaluation test requests, providing testing recommendations and implement reflex testing in molecular pathology and cytogenetics. They will also learn how to interpret test results and make clinical assessment for patient care management, including prognosis and therapy.
Conclusions: One of the emerging trends in healthcare is precision medicine and diagnostics, whereby laboratory testing enables tailored diagnosis and treatment. Appropriate utilization of molecular testing is critical in clinical practice to provide cost-effective care and enhance patient experience.
Disclosures: Nothing to disclose.
Funding: None.